Restriction on length of Malarone use lifted

24 October 2012

Prescribing information for Malarone and Malarone Paediatric (atovaquone/proguanil) has been updated to remove the maximum recommended duration of use.

Malarone should be initiated 24–48 hours before entering a malaria endemic area | SCIENCE PHOTO LIBRARY

Use of the antimalarials for the prophylaxis of P. falciparum disease is no longer limited to a maximum of 28 days in an endemic area. The duration of use should now be determined by the prescriber.

Guidance issued by the HPA in 2007 suggests that Malarone can be used for up to one year or longer.

View Malarone and Malarone Paediatric drug records

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

More from MIMS

Pregnant woman having an ultrasound scan with a female sonographer

Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA

A National Patient Safety Alert (NatPSA) has been issued...

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New and deleted indications - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest changes to...

Drug shortages - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...